A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.

Also called NCT03769623

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 206 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03769623
Other papers using this trial's data
  • Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study JACC. Cardiovascular interventions, 2022-06-27 DOI, PubMed 35738744

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03769623. Randomized; single masking; primary purpose treatment. Start 2019-06-25 (actual); primary completion 2021-02-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease
Acronym
Brave
Intervention (Device)
Biolimus
Intervention (Device)
Powerline
Lead sponsor
JW Medical Systems Ltd (class: industry)

Record details

Record id
cardio:ct-nct03769623
Content hash
9ae6e934c8c937f5954c793191988f2a594290cefb9ecc8646ab4b4fdbf3834f